Risk factors for primary congenital glaucoma in the National Birth Defects Prevention Study

被引:15
|
作者
Forestieri, Nina E. [1 ]
Desrosiers, Tania A. [2 ]
Freedman, Sharon F. [3 ]
Aylsworth, Arthur S. [4 ]
Voltzke, Kristin [2 ]
Olshan, Andrew F. [2 ]
Meyer, Robert E. [1 ,5 ]
机构
[1] State Ctr Hlth Stat, North Carolina Birth Defects Monitoring Program, Raleigh, NC USA
[2] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA
[3] Duke Univ, Med Ctr, Dept Ophthalmol & Pediat, Durham, NC USA
[4] Univ N Carolina, Dept Pediat & Genet, Chapel Hill, NC 27515 USA
[5] Univ N Carolina, Dept Maternal & Child Hlth, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA
关键词
population-based study; primary congenital glaucoma; risk factors; ALCOHOL-CONSUMPTION; GESTATIONAL-AGE; GENE-MUTATIONS; MEDICATION USE; CYP1B1; PREGNANCY; INFANTS; SMOKING; WEIGHT; BORN;
D O I
10.1002/ajmg.a.61296
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Primary congenital glaucoma (PCG) is a rare but serious birth defect. Genetic mutations have been implicated in the development of PCG, but little is known about nongenetic risk factors. This study investigates potential risk factors for PCG in the National Birth Defects Prevention Study (NBDPS), a large population-based case-control study of major birth defects in the United States. The analysis includes case infants with PCG (N = 107) and control infants without birth defects (N = 10,084) enrolled in NBDPS from birth years 2000-2011. Pregnancy/infant clinical characteristics, demographics, and parental health history were collected through maternal interview. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were computed to examine associations with all PCG cases and isolated PCG cases without other major malformations. Associations with all the cases included term low birth weight (<2,500 g; aOR = 2.80, CI 1.59-4.94), non-Hispanic black maternal race/ethnicity (aOR = 2.42, CI 1.42-4.13), maternal history of seizure (aOR = 2.73, CI 1.25-5.97), maternal antihypertensive use (aOR = 3.60, CI 1.52-8.53), and maternal sexually transmitted infection (aOR = 2.75, CI 1.17-6.44). These factors were also associated with isolated PCG, as was maternal use of nonsteroidal anti-inflammatory drugs (aOR = 2.70, CI 1.15-6.34). This study is among the first to examine a wide array of potential risk factors for PCG in a population-based sample.
引用
收藏
页码:1846 / 1856
页数:11
相关论文
共 50 条
  • [21] Acetaminophen Use in Pregnancy and Risk of Birth Defects Findings From the National Birth Defects Prevention Study
    Feldkamp, Marcia L.
    Meyer, Robert E.
    Krikov, Sergey
    Botto, Lorenzo D.
    OBSTETRICS AND GYNECOLOGY, 2010, 115 (01): : 109 - 115
  • [22] Periconceptional Benzodiazepine Use and the Risk for Birth Defects: Data from the National Birth Defects Prevention Study
    Tinker, Sarah
    Reefhuis, Jennita
    Broussard, Cheryl
    Gilboa, Suzanne
    Bitsko, Rebecca
    Werler, Martha
    Mitchell, Allen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 256 - 257
  • [23] Fluconazole use and birth defects in the National Birth Defects Prevention Study
    Howley, Meredith M.
    Carter, Tonia C.
    Browne, Marilyn L.
    Romitti, Paul A.
    Cunniff, Christopher M.
    Druschel, Charlotte M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (05) : 657.e1 - 657.e9
  • [24] Early pregnancy vitamin D status and risk of select congenital anomalies in the National Birth Defects Prevention Study
    Adrien, Nedghie
    Orta, Olivia R.
    Nestoridi, Eirini
    Carmichael, Suzan L.
    Yazdy, Mahsa M.
    BIRTH DEFECTS RESEARCH, 2023, 115 (03): : 290 - 301
  • [25] Clinical and risk factor analysis of cloacal defects in the National Birth Defects Prevention Study
    Keppler-Noreuil, Kim M.
    Conway, Kristin M.
    Shen, Dereck
    Rhoads, Anthony J.
    Carey, John C.
    Romitti, Paul A.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2017, 173 (11) : 2873 - 2885
  • [26] Potential risk factors for Ebstein anomaly, National Birth Defects Prevention Study, 1997-2011
    Downing, Karrie F.
    Riehle-Colarusso, Tiffany
    Gilboa, Suzanne M.
    Lin, Angela E.
    Oster, Matthew E.
    Tinker, Sarah C.
    Farr, Sherry L.
    CARDIOLOGY IN THE YOUNG, 2019, 29 (06) : 819 - 827
  • [27] Risk factors for isolated biliary atresia, National Birth Defects Prevention Study, 1997-2002
    The, Natalie S.
    Honein, Margaret A.
    Caton, Alissa R.
    Moore, Cynthia A.
    Siega-Riz, Anna Maria
    Druschel, Charlotte M.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2007, 143A (19) : 2274 - 2284
  • [28] Maternal Smoking and Congenital Heart Defects, National Birth Defects Prevention Study, 1997-2011
    Bolin, Elijah H.
    Gokun, Yevgeniya
    Romitti, Paul A.
    Tinker, Sarah C.
    Summers, April D.
    Roberson, Paula K.
    Hobbs, Charlotte A.
    Malik, Sadia
    Botto, Lorenzo D.
    Nembhard, Wendy N.
    JOURNAL OF PEDIATRICS, 2022, 240 : 79 - +
  • [29] Maternal Exposure to Venlafaxine and Risk for Birth Defects, National Birth Defects Prevention Study, 1997-2007
    Duwe, Kara
    Rasmussen, Sonja
    Louik, Carol
    Colarusso, Tiffany
    Reefhuis, Jennita
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S264 - S265
  • [30] Asthma Medication Use and Risk of Birth Defects: National Birth Defects Prevention Study, 1997-2011
    Howley, Meredith M.
    Papadopoulos, Eleni A.
    Van Bennekom, Carla M.
    Van Zutphen, Alissa R.
    Carmichael, Suzan L.
    Munsie, JeanPierre W.
    Herdt, Michele L.
    Browne, Marilyn L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (10): : 3490 - +